MedTrace Logo

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

NCT06112353 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2026-01-23

No results posted yet for this study

Summary

The purpose of this research study is to see the outcome of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (in hours) to first bowel movement and tolerance for solid food (GI-2 recovery) following bowel resection surgery

Conditions

  • Intestinal Disease

Interventions

DRUG

Neostigmine Injectable Solution

Examine GI-2 recovery

DRUG

Sugammadex injection

Examine GI-2 recovery

Sponsors & Collaborators

Principal Investigators

  • Robert R Field, MD · Associate Clinical Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-17
Primary Completion
2026-07-31
Completion
2026-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06112353 on ClinicalTrials.gov